Neurology of inherited glycosylation disorders

[1]  B. Harding,et al.  Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. , 1991, Archives of disease in childhood.

[2]  C. Nordborg,et al.  Sural Nerve Pathology in the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[3]  B. Hagberg,et al.  Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders. , 1993, Pediatric neurology.

[4]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[5]  T. Miyata,et al.  Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. , 1994, The New England journal of medicine.

[6]  H. Freeze,et al.  Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. , 1996, The Journal of clinical investigation.

[7]  E. Mayatepek,et al.  Continuous mannose infusion in carbohydrate‐deficient glycoprotein syndrome type I , 1997, Acta paediatrica.

[8]  R. Biancheri,et al.  Neurophysiological findings in a case of carbohydrate-deficient glycoprotein (CDG) syndrome type I with phosphomannomutase deficiency. , 1998, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[9]  C. Adamsbaum,et al.  Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1 , 1999, Pediatric Radiology.

[10]  Carolyn R. Bertozzi,et al.  Essentials of Glycobiology , 1999 .

[11]  Gert Matthijs,et al.  Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic , 2000, Human Genetics.

[12]  H. Freeze,et al.  Analysis of multiple mutations in the hALG6 gene in a patient with congenital disorder of glycosylation Ic. , 2000, Molecular genetics and metabolism.

[13]  J. Hofsteenge,et al.  Protein C-mannosylation: facts and questions. , 2000, Acta biochimica Polonica.

[14]  A. Munnich,et al.  A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases , 2001, Journal of medical genetics.

[15]  D. Krasnewich,et al.  Neurologic Course of Congenital Disorders of Glycosylation , 2001, Journal of child neurology.

[16]  K. Hwa.  Glycosyl phosphatidylinositol-linked glycoconjugates: structure, biosynthesis and function. , 2001, Advances in experimental medicine and biology.

[17]  I. Mader,et al.  Congenital disorder of glycosylation type Ia: benign clinical course in a new genetic variant , 2002, Child's Nervous System.

[18]  S. Kjaergaard,et al.  Ophthalmic manifestations of congenital disorder of glycosylation type 1a , 2003, Ophthalmic genetics.

[19]  G. Matthijs,et al.  Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia. , 2003, Neuropediatrics.

[20]  S. Hakomori.  Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization , 2004, Glycoconjugate Journal.

[21]  J. Hancock.  GPI-anchor synthesis: Ras takes charge. , 2004, Developmental cell.

[22]  M. Lehrman,et al.  Metformin-stimulated Mannose Transport in Dermal Fibroblasts* , 2004, Journal of Biological Chemistry.

[23]  O. Bohorov,et al.  Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder , 2004, Nature Medicine.

[24]  R. Dwek,et al.  Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase , 2004, Nature Genetics.

[25]  Glycosylation type Ic disorder: idiopathic intracranial hypertension and retinal degeneration , 2005, British Journal of Ophthalmology.

[26]  Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient , 2005, American journal of medical genetics. Part A.

[27]  R. Houlston,et al.  Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency , 2006, Nature Medicine.

[28]  I. Pascual-Castroviejo,et al.  Ataxia cerebelosa de Norman-Jaeken: Presentación de siete pacientes españoles , 2006 .

[29]  J. Vajsar,et al.  Walker-Warburg syndrome , 2006, Orphanet journal of rare diseases.

[30]  N. Callewaert,et al.  Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation. , 2006, Biochemical and biophysical research communications.

[32]  Hudson H. Freeze,et al.  Genetic defects in the human glycome , 2006, Nature Reviews Genetics.

[33]  G. Matthijs,et al.  Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening , 2007, Journal of Neurology.

[34]  J. Denecke,et al.  A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. , 2007, American journal of human genetics.

[35]  Arthur D Lander,et al.  Morpheus Unbound: Reimagining the Morphogen Gradient , 2007, Cell.

[36]  H. Freeze.  Congenital Disorders of Glycosylation: CDG-I, CDG-II, and beyond. , 2007, Current molecular medicine.

[37]  Y. Maeda,et al.  Targeted therapy for inherited GPI deficiency. , 2007, The New England journal of medicine.

[38]  H. Freeze,et al.  COG8 deficiency causes new congenital disorder of glycosylation type IIh. , 2007, Human molecular genetics.

[39]  Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. , 2007 .

[40]  D. Krasnewich,et al.  Clinical features in adults with congenital disorders of glycosylation type Ia (CDG‐Ia) , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.

[41]  M. Krieger,et al.  A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. , 2007, Human molecular genetics.

[42]  Qing Nie,et al.  Computational analysis of BMP gradients in dorsal-ventral patterning of the zebrafish embryo. , 2007, Journal of theoretical biology.

[43]  D. Appleton,et al.  Congenital disorder of glycosylation type 1a: Three siblings with a mild neurological phenotype , 2007, Journal of Clinical Neuroscience.

[44]  B. Galeano,et al.  Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. , 2007, The Journal of clinical investigation.

[45]  J. Gécz,et al.  Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. , 2008, American journal of human genetics.

[46]  E. Mercuri,et al.  Brain involvement in muscular dystrophies with defective dystroglycan glycosylation , 2008, Annals of neurology.

[47]  H. Brunner,et al.  Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation , 2008, European Journal of Human Genetics.

[48]  T. Hennet,et al.  On the nomenclature of congenital disorders of glycosylation (CDG) , 2008, Journal of Inherited Metabolic Disease.

[49]  Gert Matthijs,et al.  Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2 , 2008, Nature Genetics.

[50]  Laura Vilarinho,et al.  Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease. , 2008, Clinical chemistry.

[51]  Huilin Li,et al.  Structure of the oligosaccharyl transferase complex at 12 A resolution. , 2008, Structure.

[52]  H. Ropers,et al.  A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. , 2008, American journal of human genetics.

[53]  J. Esko,et al.  Proteoglycans and Sulfated Glycosaminoglycans , 2009 .

[54]  Thierry Hennet,et al.  Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol‐linked oligosaccharides , 2009, Human mutation.

[55]  J. Hofsteenge,et al.  Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. , 2009, American journal of human genetics.

[56]  Ron A Wevers,et al.  Autosomal recessive cutis laxa syndrome revisited , 2009, European Journal of Human Genetics.

[57]  R. Morimoto,et al.  Biological and chemical approaches to diseases of proteostasis deficiency. , 2009, Annual review of biochemistry.

[58]  B. Fernandez,et al.  Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival. , 2009, Human molecular genetics.

[59]  G. Matthijs,et al.  Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations. , 2009, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[60]  H. Freeze.  Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients. , 2009, Biochimica et biophysica acta.

[61]  D. Ungar.  Golgi linked protein glycosylation and associated diseases. , 2009, Seminars in cell & developmental biology.

[62]  J. Dennis,et al.  Metabolism, Cell Surface Organization, and Disease , 2009, Cell.

[63]  Inka Brockhausen,et al.  O-GalNAc Glycans , 2009 .

[64]  Matthias Baumgartner,et al.  Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation. , 2009, Human molecular genetics.

[65]  Other Classes of ER/Golgi-derived Glycans , 2009 .

[66]  J. Hewitt.  Abnormal glycosylation of dystroglycan in human genetic disease. , 2009, Biochimica et biophysica acta.

[67]  S. Grunewald.  The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). , 2009 .

[68]  P. de Lonlay,et al.  The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. , 2009, Biochimica et biophysica acta.

[69]  Masao Kobayashi,et al.  Different neuroradiological findings during two stroke-like episodes in a patient with a congenital disorder of glycosylation type Ia , 2009, Brain and Development.

[70]  W. Annaert,et al.  Golgi function and dysfunction in the first COG4-deficient CDG type II patient , 2009, Human molecular genetics.

[71]  Sebastian Bauer,et al.  Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome , 2010, Nature Genetics.

[72]  H. Freeze,et al.  SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder , 2010, Cell.

[73]  J. van Reeuwijk,et al.  A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. , 2010, Brain : a journal of neurology.

[74]  I. Nishino,et al.  A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/ hereditary inclusion body myopathy, a sugar-deficient myopathy: a review , 2010, Therapeutic advances in neurological disorders.

[75]  A. Munnich,et al.  Posterior fossa imaging in 158 children with ataxia. , 2010, Journal of neuroradiology. Journal de neuroradiologie.

[76]  Yukishige Ito,et al.  C-Mannosylated peptides derived from the thrombospondin type 1 repeat interact with Hsc70 to modulate its signaling in RAW264.7 cells. , 2010, Glycobiology.

[77]  W. Balch,et al.  The Proteome in Balance , 2010, Science.

[78]  Gert Matthijs,et al.  A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): a case report , 2010, Orphanet journal of rare diseases.

[79]  R. Pfundt,et al.  Skeletal dysplasia with brachytelephalangy in a patient with a congenital disorder of glycosylation due to ALG6 gene mutations , 2010, Clinical genetics.

[80]  B. Tseng,et al.  Consensus Statement on Standard of Care for Congenital Muscular Dystrophies , 2010, Journal of child neurology.

[81]  Florian Gnad,et al.  Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints , 2010, Cell.

[82]  C. Thiel,et al.  Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. , 2010, Human molecular genetics.

[83]  H. Takeuchi,et al.  Role of glycosylation of Notch in development. , 2010, Seminars in cell & developmental biology.

[84]  Liping Yu,et al.  O-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding , 2010, Science.

[85]  A. Afenjar,et al.  Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations , 2010, Journal of Medical Genetics.

[86]  John R Yates,et al.  Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. , 2010, Nature chemical biology.

[87]  P. Stanley,et al.  Roles of glycosylation in Notch signaling. , 2010, Current topics in developmental biology.

[88]  N. Senzer,et al.  Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex. , 2011, Human gene therapy.

[89]  Y. Maeda,et al.  Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins. , 2011, Progress in lipid research.

[90]  H. Freeze,et al.  The congenital disorders of glycosylation: A multifaceted group of syndromes , 2006, NeuroRX.

[91]  T. Strom,et al.  Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. , 2011, American journal of human genetics.

[92]  Gert Matthijs,et al.  How Golgi glycosylation meets and needs trafficking: the case of the COG complex. , 2011, Glycobiology.

[93]  Madhuri R Hegde,et al.  Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation , 2011, Genetics in Medicine.

[94]  B. Choudhury,et al.  N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis* , 2011, The Journal of Biological Chemistry.

[95]  K. Campbell,et al.  Glycomic Analyses of Mouse Models of Congenital Muscular Dystrophy* , 2011, The Journal of Biological Chemistry.

[96]  A. Cideciyan,et al.  A missense mutation in DHDDS, encoding dehydrodolichyl diphosphate synthase, is associated with autosomal-recessive retinitis pigmentosa in Ashkenazi Jews. , 2011, American journal of human genetics.

[97]  J. Dennis,et al.  Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis , 2011, Nature communications.

[98]  Susan C. Brown,et al.  Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies. , 2011, Current opinion in neurology.

[99]  H. Freeze,et al.  Golgi glycosylation and human inherited diseases. , 2011, Cold Spring Harbor perspectives in biology.

[100]  H. Freeze,et al.  Phosphomannose Isomerase Inhibitors Improve N-Glycosylation in Selected Phosphomannomutase-deficient Fibroblasts* , 2011, The Journal of Biological Chemistry.

[101]  Carol A. Bocchini,et al.  A new face and new challenges for Online Mendelian Inheritance in Man (OMIM®) , 2011, Human mutation.

[102]  G. Rechavi,et al.  Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN , 2011, Journal of Medical Genetics.

[103]  S. Lev,et al.  The COG complex interacts directly with Syntaxin 6 and positively regulates endosome-to-TGN retrograde transport , 2011, The Journal of cell biology.

[104]  H. Freeze,et al.  Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic). , 2011, Molecular genetics and metabolism.

[105]  Mild Clinical and Biochemical Phenotype in Two Patients with PMM2-CDG (Congenital Disorder of Glycosylation Ia) , 2012, The Cerebellum.

[106]  J. Schuurs-Hoeijmakers,et al.  Autosomal Recessive Dilated Cardiomyopathy due to DOLK Mutations Results from Abnormal Dystroglycan O-Mannosylation , 2011, PLoS genetics.

[107]  E. Kerem,et al.  Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. , 2011, American journal of respiratory and critical care medicine.

[108]  H. Freeze,et al.  Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia. , 2011, Journal of medicinal chemistry.

[109]  H. Gröne,et al.  Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice , 2011, Nature Medicine.

[110]  Rena A. Godfrey,et al.  The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases , 2011, Genetics in Medicine.

[111]  M. Hegde,et al.  Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. , 2012, American journal of human genetics.

[112]  M. Hegde,et al.  DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation. , 2012, American journal of human genetics.

[113]  Linzhao Cheng,et al.  The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. , 2012, American journal of human genetics.